Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
2.190
+0.130 (6.31%)
Nov 21, 2024, 12:10 PM EST - Market open
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $22.28 million as of November 21, 2024. Its market cap has increased by 25.17% in one year.
Market Cap
22.28M
Enterprise Value
9.81M
1-Year Change
25.17%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $22.28M, a decrease of -80.68%. That is a compound annual growth rate of -21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 21.00M | 20.00% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 22.00M |
| NeuroSense Therapeutics | 21.81M |
| NeurAxis | 21.64M |
| Bionano Genomics | 21.53M |
| NeuroBo Pharmaceuticals | 21.45M |
| Cyclo Therapeutics | 20.93M |
| BriaCell Therapeutics | 20.92M |
| NeuroOne Medical Technologies | 20.64M |